Envíos recientes

Machine learning-based spatial characterization of tumor-immune microenvironment in the EORTC 10994/BIG 1-00 early breast cancer trial

Manikis, Georgios C.; Acs, Balazs; Johansson, Hemming; Zerdes, Ioannis; Matikas, Alexios; Mezheyeuski, Artur (Nature Portfolio, 2025-03-07)

Harnessing transcriptional regulation of alternative end-joining to predict cancer treatment

Espin Garcia, Roderic; Medina-Jover, Ferran; Sigüenza-Andrade, Javier; Farran Matas, Sònia; Mateo, Francesca; Figueras, Agnès; Serra, Violeta (Oxford University Press, 2025-03)

TUXEDO-4: phase II study of trastuzumab-deruxtecan in HER2-low breast cancer with new or progressing brain metastases

Marhold, Maximilian; Vaz Batista, Marta; Blancas López-Barajas, Isabel; morales-estevez, cristina; Saavedra, Cristina; Saura Manich, Cristina (Taylor & Francis, 2025)

Considerations and recommendations from the ISMRM Diffusion Study Group for preclinical diffusion MRI: Part 3—Ex vivo imaging: Data processing, comparisons with microscopy, and tractography

Schilling, Kurt; Howard, Amy; Ianus, Andrada; Hansen, Brian; Barrett, Rachel L. C.; Grussu, Francesco (Wiley, 2025-06)

Considerations and recommendations from the ISMRM diffusion study group for preclinical diffusion MRI: Part 1: In vivo small-animal imaging

Jelescu, Ileana; Hansen, Brian; Barrett, Rachel L. C.; Aggarwal, Manisha; Grussu, Francesco; Ianus, Andrada (Wiley, 2025-06)

Scientia. Depósito de Información Digital del Departamento de Salud

Vall d'Hebron Institut d'Oncologia - VHIO: Envíos recientes

Machine learning-based spatial characterization of tumor-immune microenvironment in the EORTC 10994/BIG 1-00 early breast cancer trial

Harnessing transcriptional regulation of alternative end-joining to predict cancer treatment

TUXEDO-4: phase II study of trastuzumab-deruxtecan in HER2-low breast cancer with new or progressing brain metastases

Considerations and recommendations from the ISMRM Diffusion Study Group for preclinical diffusion MRI: Part 3—Ex vivo imaging: Data processing, comparisons with microscopy, and tractography

Considerations and recommendations from the ISMRM diffusion study group for preclinical diffusion MRI: Part 1: In vivo small-animal imaging

Scientia. Depósito de Información Digital del Departamento de Salud

Vall d'Hebron Institut d'Oncologia - VHIO: Envíos recientes

Machine learning-based spatial characterization of tumor-immune microenvironment in the EORTC 10994/BIG 1-00 early breast cancer trial ﻿

Harnessing transcriptional regulation of alternative end-joining to predict cancer treatment ﻿

TUXEDO-4: phase II study of trastuzumab-deruxtecan in HER2-low breast cancer with new or progressing brain metastases ﻿

Considerations and recommendations from the ISMRM Diffusion Study Group for preclinical diffusion MRI: Part 3—Ex vivo imaging: Data processing, comparisons with microscopy, and tractography ﻿

Considerations and recommendations from the ISMRM diffusion study group for preclinical diffusion MRI: Part 1: In vivo small-animal imaging ﻿

Machine learning-based spatial characterization of tumor-immune microenvironment in the EORTC 10994/BIG 1-00 early breast cancer trial

Harnessing transcriptional regulation of alternative end-joining to predict cancer treatment

TUXEDO-4: phase II study of trastuzumab-deruxtecan in HER2-low breast cancer with new or progressing brain metastases

Considerations and recommendations from the ISMRM Diffusion Study Group for preclinical diffusion MRI: Part 3—Ex vivo imaging: Data processing, comparisons with microscopy, and tractography

Considerations and recommendations from the ISMRM diffusion study group for preclinical diffusion MRI: Part 1: In vivo small-animal imaging